Lv3
246 积分 2024-08-03 加入
Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: a systematic review
7天前
已完结
Evaluation of LRRK2 G2019S penetrance
7天前
已完结
α-Synuclein in synaptic function and dysfunction
12天前
已完结
MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition
19天前
已完结
Discovery of Potent, Selective, CNS-Penetrant Macrocyclic LRRK2 Inhibitors for the Treatment of Parkinson’s Disease
19天前
已完结
Discovery of Highly Potent, Selective, and Brain-Penetrant Aminopyrazole Leucine-Rich Repeat Kinase 2 (LRRK2) Small Molecule Inhibitors
19天前
已完结
Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease
19天前
已完结
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson’s Disease
20天前
已完结
LRRK2 activation in idiopathic Parkinson’s disease
20天前
已完结
LRRK2 activation in idiopathic Parkinson’s disease
27天前
已完结
皖公网安备34019202002308
